---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-000953"
form_type: "8-K"
ticker: "ATR"
cik: "0000896622"
company_name: "APTARGROUP, INC."
filed_at: "2021-07-30T23:59:59+00:00"
generated_at: "2026-06-30T00:39:05.620320+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aptar Q2 sales up 16% to $811M, adj EPS $0.91 (+7%), core sales +10%; Q3 guidance $0.90-$0.98

## Summary
- Reported sales $811M (+16% YoY); core sales +10% aided by double-digit growth in Beauty+Home and Food+Beverage.
- Reported EPS $0.81 (+29%); adj EPS $0.91 (+7% neutralizing currency); net income $55M (+32%).
- Pharma core sales +2% as destocking of allergic rhinitis/cough-cold inventory continues; elastomer demand strong.
- Free cash flow H1 $39M (down 63%) due to higher capex and working capital; cash from ops $176M (-23%).
- Q3 adj EPS guidance $0.90-$0.98; expects gradual improvement through H2 with acceleration toward year-end.

## SEC filing metadata
- accession: 0001157523-21-000953
- form_type: 8-K
- ticker: ATR
- cik: 0000896622
- company_name: APTARGROUP, INC.
- filed_at: 2021-07-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896622/000115752321000953/0001157523-21-000953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896622/000115752321000953/a52468729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-000953
- JSON: https://secwatch.observer/filing/0001157523-21-000953.json
- Plain text: https://secwatch.observer/filing/0001157523-21-000953.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.